Robert L Parkinson Jr's Net Worth
$102 Million
Who is Robert L Parkinson Jr?
Robert L Parkinson Jr has an estimated net worth of $102 Million. This is based on reported shares across multiple companies, which include BAXTER INTERNATIONAL INC, and ENZON PHARMACEUTICALS INC.
SEC CIK
Robert L Parkinson Jr's CIK is 0001168252
Past Insider Trading and Trends
2004 was Robert L Parkinson Jr's most active year for acquiring shares with 11 total transactions. Robert L Parkinson Jr's most active month to acquire stocks was the month of February. 2011 was Robert L Parkinson Jr's most active year for disposing of shares, totalling 10 transactions. Robert L Parkinson Jr's most active month to dispose stocks was the month of February. 2013 saw Robert L Parkinson Jr paying a total of $26,163,637.50 for 1,994,162 shares, this is the most they've acquired in one year. In 2013 Robert L Parkinson Jr cashed out on 746,351 shares for a total of $54,588,791.53, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BAXTER INTERNATIONAL INC (BAX) Snapshot price: $38.96
Chairman the Board and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.11% | 7.6K |
—
|
—
| 693.4K |
Aug 11
| |||
Form 4
| +9.73% | 60.58K |
—
|
—
| 683.32K |
Jul 1
| |||
Form 4
| +10.96% | 61.38K |
$69.21 | -$606,418.02 | 621.34K |
Mar 3 - Mar 5
| |||
Form 4
| +6.33% | 33.34K |
—
|
—
| 559.95K |
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
| +6.38% | 31.36K |
$68.40 | -$714,780.00 | 523.29K |
Jan 29
| |||
Form 4
| +5.37% | 25K |
$34.85 | $871,250.00 | 490.49K |
Scheduled
|
Aug 5
| ||
Form 4
|
—
|
0
|
$54.09 | -$27,926,025.51 | 465.49K |
Scheduled
|
Jul 31 - Aug 1
| ||
Form 4
| +10.73% | 45K |
—
|
—
| 464.52K |
Mar 5
| |||
Form 4
| +7.14% | 27.97K |
$66.52 | -$1,370,378.52 | 419.52K |
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
| +14.64% | 50K |
$43.53 | -$4,921,222.00 | 391.55K |
Scheduled
|
Oct 27
| ||
Form 4
|
—
|
0
|
$43.46 | -$7,611,263.50 | 341.55K |
Scheduled
|
Oct 24 - Oct 26
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
| +6.77% | 21.67K |
$50.30 | -$605,612.00 | 341.55K |
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
| +77.44% | 139.6K |
$60.80 | -$5,374,720.00 | 319.88K |
Jan 20
| |||
Form 4
| -4.09% | -7.69K |
$51.07 | -$392,881.51 | 180.28K |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
| -8.10% | -16.56K |
$56.27 | -$932,056.28 | 187.97K |
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
| -7.44% | -16.43K |
$50.74 | -$833,607.46 | 204.53K |
Mar 14 - Mar 15
| |||
Form 4
| +29.55% | 50.41K |
$38.35 | -$310,366.55 | 220.96K |
Mar 14
| |||
Form 4
| +0.07% | 119 |
—
|
—
| 170.56K |
Feb 16
| |||
Form 4
| +89.38% | 80.44K |
—
|
—
| 170.44K |
Mar 14
| |||
Form 4
| +80.00% | 40K |
$34.23 | $1,369,033.00 | 90K |
Feb 16
| |||
Form 4
| +400.00% | 40K |
$32.77 | $1,310,774.00 | 50K |
Apr 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ENZON PHARMACEUTICALS INC (ENZN) Snapshot price: $0.15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +27.13% | 1.44K |
—
|
—
| 6.74K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31 - Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||